Features
1 / 5
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06Oct 11, 2022
mRNA
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-02Oct 11, 2022
Cell Therapy
Targeting Cancers by Leveraging the Biology of Gamma Delta T Cells
Bryan Kobel
TC Biopharm
PAO-07-022-CL-03Aug 09, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06Jul 02, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04Jun 24, 2022
Quantum Computing
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-10Jun 24, 2022
Column: Technology
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-02Mar 23, 2022
COVID-19 Vaccines
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-05Mar 18, 2022
Mesenchymal Stem Cells
The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-21-NI-01Mar 12, 2022
Feature Story
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-002Dec 09, 2020
Feature Story
Wearable Technology: Targeting a Range of Uses and Indications
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-003Dec 09, 2020
Feature Story
Wearable Technology: Their Future in Clinical Trials and the Real World
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q4-20-NI-004Dec 09, 2020
Feature Story
The COVID-19 Pandemic Magnifies Pharmaceutical Supply Chain Issues
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-002Sep 29, 2020
Feature Story
The Growing Importance of Local Manufacturing and Nearby Outsourcing Partners
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-003Sep 29, 2020
Feature Story
Rethinking the Global Pharmaceutical Supply Chain Post-COVID-19
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q3-20-NI-004Sep 29, 2020
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001Jul 01, 2020
Molecules
Molecules that Changed Medicine
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-002Jul 01, 2020
Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-004Jul 01, 2020
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
MilliporeSigma
PR-M04-20-NI-032-1596Apr 23, 2020
COVID-19
COVID-19: A Look at the Virus, its Epidemiology, Therapeutic and Vaccine Development Efforts and Impacts of the Pandemic
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAO-Q2-20-NI-001Apr 07, 2020
1 / 5